Filter by

  • Publication Year
  • Availability
  • Attachment
  • Collection Type
    See More
  • General Material Designation
    See More
  • Location
    See More
  • Language
Found 3 from your keywords: subject="BCG"
cover
IMMUNE RESPONSES STUDY OF VACCAE (V7) AND M72/ASO1 AS NOVEL TUBERCULOSIS VACC…
Comment Share
Gabriella Thimoty

Tuberculosis for a long period of time has become part of the cause for the mortality rate that burdened numerous patients around the world. Not only physically but also socioeconomically burdened the patient due to the long period of the regimen that the patient has to put through. Nevertheless, recent vaccine candidates for tuberculosis now have been researched that are said to be better able…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
BM 21-017
cover
Cross-Reactivity Analysis between SARS-CoV-2 T Cell Epitopes with Epitopes fr…
Comment Share
Angelika

Nearly all countries worldwide have been affected by the enormity of COVID-19 caused by SARS-CoV-2, including Indonesia. This pandemic has a variation in symptoms and the number of deaths among Indonesian COVID-19 patients, which could be explained by the nonspecific immunity provided by the cross-reactive epitopes from LAVs (BCG, OPV, and MMR). However, there is still a lack of base eviden…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
BM 22-019
cover
Systematic Review: Comparison Study on WHO Approved Tuberculosis Vaccine Cand…
Comment Share
Jonathan Hendrik Bera

Tuberculosis is a disease caused by Mycobacterium tuberculosis which mainly attacks the lung but could also cause disease in other organs such as lymphatic system, bone, skin and liver. According to WHO, Indonesia is ranked second in total tuberculosis per year in the w orld. C urrently tuberculosis is handled in Indonesia with medication regimen to cure the disease and BCG vaccination in child…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
BM 21-004